GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value: $558M (100.0% shares, 0.0% debt)

Holdings (38)

ARENA PHARMACEUTICALS INC 7.4%
Value $41.16M Shares 2,439,930 Est. Cost $16.87 Unrealized
ADAMAS PHARMACEUTICALS INC 6.9%
Value $38.76M Shares 2,216,351 Est. Cost $18.31 Unrealized
VNDA VANDA PHARMACEUTICALS INC 6.5%
Value $36.38M Shares 2,232,238 Est. Cost $10.87 Unrealized +32.6%
ZOGENIX INC 6.3%
Value $35.39M Shares 2,440,959 Est. Cost $11.56 Unrealized
PTCT PTC THERAPEUTICS INC 6.2%
Value $34.83M Shares 1,900,000 Est. Cost $12.42 Unrealized +8.5%
SYNERGY PHARMACEUTICALS DEL 5.8%
Value $32.15M Shares 7,223,509 Est. Cost $4.54 Unrealized
CONCERT PHARMACEUTICALS INC 5.0%
Value $27.9M Shares 2,000,000 Est. Cost $17.06 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 4.9%
Value $27.6M Shares 600,000 Est. Cost $43.70 Unrealized +11.0%
RIGEL PHARMACEUTICALS INC 4.5%
Value $24.86M Shares 9,105,691 Est. Cost $3.31 Unrealized
FOAMIX PHARMACEUTICALS LTD 4.0%
Value $22.19M Shares 4,781,708 Est. Cost $7.50 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.0%
Value $22.08M Shares 276,800 Est. Cost $62.99 Unrealized +1.5%
SAGE THERAPEUTICS INC 3.5%
Value $19.42M Shares 243,800 Est. Cost $36.69 Unrealized
SELECTA BIOSCIENCES INC 3.3%
Value $18.62M Shares 937,500 Est. Cost $19.86 Unrealized
IGNYTA INC 3.2%
Value $18.11M Shares 1,749,323 Est. Cost $5.55 Unrealized
DBV TECHNOLOGIES SA 3.2%
Value $17.86M Shares 500,000 Est. Cost $35.48 Unrealized
ACCELERON PHARMA INC 2.7%
Value $15M Shares 493,500 Est. Cost $28.01 Unrealized
PCRX PACIRA PHARMACEUTICALS INC 2.6%
Value $14.31M Shares 300,000 Est. Cost $46.40 Unrealized 0.0%
SEATTLE GENETICS INC 2.3%
Value $12.91M Shares 249,500 Est. Cost Unrealized
PORTOLA PHARMACEUTICALS INC 2.2%
Value $12.14M Shares 216,200 Est. Cost Unrealized
NEURODERM LTD 1.7%
Value $9.299M Shares 311,000 Est. Cost $26.55 Unrealized
INSM INSMED INC 1.7%
Value $9.24M Shares 538,473 Est. Cost $17.08 Unrealized 0.0%
AIMMUNE THERAPEUTICS INC 1.6%
Value $8.952M Shares 435,402 Est. Cost $20.89 Unrealized
NEWLINK GENETICS CORP 1.4%
Value $8.032M Shares 1,092,849 Est. Cost $7.35 Unrealized
BOVIE MEDICAL CORP 1.3%
Value $7.222M Shares 2,924,015 Est. Cost $2.83 Unrealized
AMARIN CORPORATION PLC 1.3%
Value $7.133M Shares 1,770,000 Est. Cost $4.03 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.3%
Value $6.985M Shares 255,400 Est. Cost $14.45 Unrealized
PTCT PTC THERAPEUTICS INC 0.9%
Value $4.766M Shares 260,000 Est. Cost $12.42 Unrealized +8.5%
DYNAVAX TECHNOLOGIES CORP 0.8%
Value $4.203M Shares 435,500 Est. Cost $9.65 Unrealized
CARA THERAPEUTICS INC 0.7%
Value $4.177M Shares 271,400 Est. Cost $15.38 Unrealized
SAGE THERAPEUTICS INC 0.7%
Value $4.109M Shares 51,600 Est. Cost $36.69 Unrealized
SUNESIS PHARMACEUTICALS INC 0.7%
Value $3.864M Shares 1,431,149 Est. Cost $4.14 Unrealized
MYOVANT SCIENCES LTD 0.5%
Value $2.9M Shares 247,899 Est. Cost $12.34 Unrealized
CONNECTURE INC 0.5%
Value $2.55M Shares 4,127,232 Est. Cost $9.01 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 0.2%
Value $1.242M Shares 169,014 Est. Cost $6.36 Unrealized 0.0%
ARADIGM CORP 0.1%
Value $835K Shares 637,279 Est. Cost $8.85 Unrealized
CARA THERAPEUTICS INC 0.1%
Value $761K Shares 49,471 Est. Cost $15.38 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.0%
Value $139K Shares 130,137 Est. Cost $6.45 Unrealized
FOLD AMICUS THERAPEUTICS INC 0.0%
Value $125K Shares 12,400 Est. Cost Unrealized